Hutchmed
Clinical trials sponsored by Hutchmed, explained in plain language.
-
New pill HMPL-506 shows promise in early blood cancer trial
Disease control Recruiting nowThis study tests a new oral drug, HMPL-506, in about 132 adults with certain blood cancers (like leukemia) that have come back or not responded to treatment. The main goals are to check the drug's safety and find the right dose. Researchers will also look at whether the drug help…
Phase: PHASE1 • Sponsor: Hutchmed • Aim: Disease control
Last updated May 01, 2026 15:58 UTC
-
New pill shows promise for rare bile duct cancer with gene mutation
Disease control Recruiting nowThis study tests an experimental drug, HMPL-453, in adults with advanced bile duct cancer that has a specific change in the FGFR2 gene. The goal is to see if the drug can shrink tumors or stop them from growing. Participants take the drug by mouth in 3-week cycles. The study is f…
Phase: PHASE2, PHASE3 • Sponsor: Hutchmed • Aim: Disease control
Last updated Apr 29, 2026 15:03 UTC